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Abstract
Human enteroviruses (HEV) are frequent human pathogens and, associated in particular with large outbreaks of aseptic
meningitis. Here, we have compiled a database of clinical HEV isolates from the Public Hospitals of Marseille, from 1985 to
2005. Amongst 654 isolates that could be characterized by complete sequencing of the VP1 gene, 98% belonged to species
HEV-B; the most frequently isolated serotypes were Echovirus E30, E11, E7, E6 and E4. The high incidence of E30 and the
recent emergence of E13 are consistent with reports worldwide and peak HEV isolation occurred mostly in the late spring
and summer months. The proportion of echoviruses has decreased across the years, while that of coxsackieviruses has
increased. Stool (the most frequent sample type) allowed detection of all identified serotypes. MRC5 (Human lung
fibroblasts) cell line was the most conducive cell line for HEV isolation (84.9% of 10 most common serotype isolates, 96.3%
in association with BGM (Buffalo green monkey kidney cells)). Previous seroneutralization-based serotype identification
demonstrated 55.4% accuracy when compared with molecular VP1 analysis. Our analysis of a large number of clinical strains
over 20 years reinforced the validity of VP1 serotyping and showed that comparative p-distance scores can be coupled with
phylogenetic analysis to provide non-ambiguous serotype identification. Phylogenetic analysis in the VP1, 2C and 3D
regions also provided evidence for recombination events amongst clinical isolates. In particular, it identified isolates with
dissimilar VP1 but almost identical nonstructural regions.
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Introduction
Human enteroviruses (HEV, family Picornaviridae) are small non-
enveloped viruses with a single-stranded RNA genome of positive
polarity. The genome is approximately 7.4 kb long. Four
structural proteins, VP1 to VP4, are assembled to form the virion
capsid of icosahedral symmetry. The most conserved regions of the
enteroviral genome are the 59non-coding region (59NCR) and the
RNA-dependent RNA polymerase [1–2]. 64 distinct human
serotypes were previously identified on the basis of their
pathogenic potential and neutralization by specific antisera. They
were then later reclassified into four species based on sequence
identity of the region coding for the VP1 capsid protein. The four
species are (i) HEV-A, (ii) HEV-B, (iii) HEV-C including Poliovirus
(PV), and (iv) HEV-D [3–4].
Laboratory detection of enteroviruses is performed today by the
‘gold standard’ method of a pan-enterovirus real-time RT-PCR in
the 59NCR, which allows the detection of all enteroviruses but not
the identification of their serotype [5]. Conventional serotyping
consists of neutralization tests with Lim Benyesh-Melnick
antiserum pools raised against prototype strains [6]. Modern day
serotype identification is based on virus isolation in cell culture and
the nucleotide sequence of the region coding for VP1 protein. VP1
sequences from prototype strains have been demonstrated to
correlate best with neutralization-based serotype, as it is the site of
major epitopes associated with serotype-specific neutralization
[7–8]. More recently, molecular protocols aiming at identifying
the HEV serotype directly from clinical samples have been
proposed [9–12].
HEV cause a wide spectrum of illnesses ranging from mild
(hand, foot and mouth disease, gastroenteritis, acute haemorrhagic
conjunctivitis) to severe and potentially life-threatening (acute
flaccid paralysis) [13–14]. Most enteroviral infections are asymp-
tomatic or subclinical but their neurotropism can cause serious
central nervous system complications such as aseptic meningitis
and encephalitis. Enteroviruses are the major cause of aseptic
meningitis in both pediatric and adult populations [15–16]. There
is currently no antiviral treatment available for HEV infection
[17].
There is worldwide circulation of enteroviruses, except for
poliovirus which remains endemic in only four countries (Pakistan,
India, Nigeria and Afghanistan) [18]. Seasonal aseptic meningitis
outbreaks due to non-polio enteroviruses have been noted to peak
in summer till early autumn in the Northern Hemisphere [19].
While the prevalent serotype varies from year to year, with co-
circulation of several serotypes a common observation, recent
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[20–24]. The molecular mechanism for enterovirus evolution
couples mutation due to viral polymerase error and homologous
recombination by template switching [25]. The evolutionary
overview of enteroviruses appears to be considered as genome
fragments in a global reservoir, subjected to independent
evolutionary forces and recombination events [26–28].
Here, we have compiled a comprehensive database of HEV
isolated at the Public Hospitals of Marseille (AP-HM), France,
spanning 1985 to 2005 with VP1 nucleotide sequences of clinical
HEV strains. We systematically analyzed it for epidemiological
information as well as trends in laboratory diagnostic techniques.
Results
Frequency of HEV isolation
Of 828 secondary cell cultures tested positive for HEV by
immunofluorescence, 654 (79%) were successfully sequenced in
the VP1 region and attributed their serotype. We identified 9 years
with significantly high HEV isolation frequency during which the
number of monthly isolates exceeded the upper control limit at
99% confidence level (UCL99=6.71, p,0.01) (Figure 1), 8 of
which saw peak HEV isolation between May andAugust, in the
late spring and summer months. The only exception was in 1987
when peak HEV isolation occurred in September and October, in
the fall. Isolation levels in 2000 and 2005 were of great amplitude,
and coincide with the occurrence of HEV epidemics in Marseille.
HEV isolates in 2000 (n=191) peaked in the summer months,
with 93.2% (n=178) occurring between May and August. 50.3%
of the isolates in 2000 were attributed to the serotype E30 (n=96),
15.7% to E13 (n=30) and 7.9% to E11 (n=15). In 2005, only
6.7% (n=24) of all cases were isolated and typed as a result of a
change in hospital diagnostic protocol. Nevertheless, the 2005
epidemic is evidenced by the number of cases diagnosed
Enterovirus-positive with real time RT-PCR (n=78, 151, 76 for
May, June and July respectively). HEV isolates during the
remaining peaks comprised numerous serotypes, including E30,
E11, E7, E18 and CVB5, without clear predominance of any one
serotype.
Serotype patterns
Overall, the 10 HEV serotypes most commonly isolated
between 1985 and 2005 all belong to the HEV-B species: in
decreasing frequency, E30, E11, E7, E6, E4, E13, CVB5, E14,
CVB3 and E18 (Figure 2) and account for 77.1% of isolates with
known serotype. The 5 most frequently encountered serotypes,
E30, E11, E7, E6 and E4 account for 56.7% of all isolates, and
remain the most prevalent serotypes even after factoring out the
2000 and 2005 epidemics. HEV-B accounted for 98% of all
isolates.
Long-term circulation patterns varied for individual serotypes.
Some serotypes have disappeared from Marseille: the last reported
cases of CVA13, CVA17, E1, E2, E3, E12, E14, E31, E32, EV74
and PV all precede 1992. On the other hand, other serotypes have
appeared with varying frequencies: CVA24 has been isolated with
extremely low frequency (4 isolates since 1996), in contrast with
E13 which reappeared in 2000 as an epidemic serotype. Only a
single E13 infection was reported in Marseille prior to the 2000
outbreak. Serotypes such as E30, E7, E6 and E4 demonstrate
more endemic patterns, with persistent isolation levels over 20
years. E30 in particular, has a strong propensity for epidemic
eruptions and was the most commonly identified enterovirus
Figure 1. Monthly distribution of Enterovirus isolates (1985–2005), and Enterovirus-positive RT-PCR diagnostic cases (2004–2005).
We identified 9 years of significantly high HEV isolation frequency during which the number of monthly isolates exceeded the upper control limit at
99% confidence level (UCL99=6.71, p,0.01). Peak isolation levels were mostly between May and August, except in 1987 in September and October.
2 epidemics were also recorded in 2000 and 2005.
doi:10.1371/journal.pone.0018022.g001
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2001, 2002 and 2005).
Classification and Regression Tree (CART)
The CART technique classified our data into groups through a
series of splits that best differentiated observations of the data
(Figure 3). The main discriminatory feature was the year of
isolation which allowed the definition of 3 temporal periods: 1985–
1987, 1988–2000 and 2001–2005. Paying attention to the change
in proportion of each virus group across these 3 periods we
observed that: (i) Poliovirus has gradually disappeared; (ii)
Frequency of HEV-A and other HEV-C and remained consis-
tently low (#2%); (iii) The proportion of coxsackieviruses has
increased from 4.9% to 24.8%, and (iv) The proportion of
echoviruses have decreased from 89.2% to 73.5%.
EV isolation by sample type and cell line
Stool is used most frequently in suspected HEV infections over
20 years, save the 2000 and 2005 epidemics during which
cerebrospinal fluid (CSF) was highly solicited. Stool samples
allowed detection of all serotypes, including most of the non HEV-
B serotypes and, notably, all the PV. Further examination of the
most common HEV serotypes revealed that 84.9% of the clinical
strains showed preferential growth in MRC5 cells, in particular the
echoviruses. The additional use of BGM cells enhanced total
recovery to 96.3% and allowed better detection of group B
coxsackieviruses and Polioviruses (Figure 4).
Accuracy of serotype identification by seroneutralization
The serotypes of 204 clinical samples initially determined at the
time of virus isolation by neutralization tests were challenged by
VP1 nucleotide sequencing. Only 113 (55.4%) were corroborated
by nucleotide sequence. Considering only serotypes with at least 4
strains, this technique was largely accurate (75–91%) for E20, E30,
E24, CVB2 and E5. It was average (50–60%) for E14, CVB5, E7,
E4 and E6 and poor (26.7–28.6%) for CVA9 and E11. No PV
strain was detected using the neutralization technique. The 4
strains that were ultimately designated as PV1 by their VP1
sequences were initially typed as E20, E21, E24 and an
adenovirus.
Phylogenetic analysis of clinical strains
Near full-length VP1 nucleotide sequences (777 nucleotides) of
HEV clinical strains were analysed in a phylogenetic tree together
with prototype reference sequences and VP1 homologues from
NCBI GenBank This overall topology of four distinct clusters
corresponding to the four HEV species is consistent with
phylogenies previously described [8]. By visualizing the frequency
of p-distance scores as a percentage of total scores, clinical VP1
scores fell into three established ranges: variants of the same
serotype (#0.25), sequences of different serotype but of the same
species (.0.25 and ,0.42) and finally, sequences of different
species ($0.42) (Figure S1). Overall, only 0.05%, 0.14% and
0.8% of the three categories respectively were exceptions to these
definitions.
Molecular evolution of EC30 and EC13
The molecular evolution of E30 was studied in detail by
phylogenetic analysis including 159 E30 VP1 sequences from the
Marseille database (Figure 5). The phylogenetic tree presented 5
temporal clusters, with all Marseille strains clustering together in
group 5 (bootstrap 74%) and the majority in a stable subgroup
characterized by their period of isolation (2000–2005). Pairwise
p-distance showed that the greatest nucleotide disparity between
Figure 2. Distribution of Enterovirus serotypes isolated in Marseille, 1985–2005. The 10 most common serotypes isolated between 1985
and 2005 in Marseille account for 77.1% of all cases. Shown in red: (in decreasing order) E30, E11, E7, E6, E4, E13, CVB5, E14, CVB3 and E18. The top 5
most frequently encountered serotypes alone account for 56.7%.
doi:10.1371/journal.pone.0018022.g002
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isolated in 2002 but which cluster differently in the phylogenetic
tree. Notably, the clinical isolate #553 and the prototype strain
Giles isolated in 1960 differed genetically by 0.255, which sits just
beyond the intra-serotype threshold of 0.25. Its persistent
circulation and the extent of its associated epidemics have
generated a large genetic diversity within E30, and may go some
way to account for this exceptional genetic distance.
The molecular evolution of E13 was also further studied by
phylogenetic analysis including 36 E13 VP1 sequences from the
Marseille database (Figure 6). All but two clinical E13 strains
were isolated between 2000 and 2002, and clustered in one distinct
group together with European and Asian strains from the same
period. Within this group, clinical isolates differed in p-distance by
no more than 0.036. In contrast, the greatest genetic distance
observed between clinical isolates was 0.242, between #369
isolated in 1987, and #375 isolated in 2000.
Evidence for recombination
To examine the extent of intraspecies recombination, we
designed primers that targeted portions of the 2C and 3D regions
that distinguished HEV-B serotypes phylogenetically from other
species. Of 65 HEV-B strains tested, 59 (90.8%) were successfully
amplified and sequenced in the 2C region and 61 (93.8%) in the
3D region. Phylogenetic trees were constructed for the VP1, 2C
and 3D genes (Figure 7). Incongruent tree topologies and
inconsistent interserotype clustering show that the genetic
relationship between different serotypes is not conserved through-
out the genome. The maximum nucleotide distance in the VP1,
2C and 3D regions was 0.42, 0.262 and 0.271 respectively. To
Figure 3. Classification by year of isolation. The Classification and Regression Tree (CART) split the data by year of isolation, describing 3
temporal periods: 1985–1987, 1988–2000 and 2001–2005. The change in proportion was observed for each virus group, with HEV-B further divided
into Echoviruses and Coxsackieviruses, while Poliovirus was regarded as separate from HEV-C.
doi:10.1371/journal.pone.0018022.g003
Figure 4. Isolation of the 10 most common Enterovirus serotypes by cell line. MRC5 cells were the most conducive culture line for 84.9% of
the samples, with the addition of BGM cell lines enhancing total sample recovery up to 96.3% and covering all serotypes.
doi:10.1371/journal.pone.0018022.g004
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all p-distance scores were normalized by expressing them as a
percentage of the maximal p-distance in nucleotides for each
region within HEV-B.
Three serotypes (E13, CVB3 and E30) with more than 4
antigenic variants in our study set were examined to evaluate
intraserotype genetic relationships. Regardless of p-distance, all
strains clustered according to their serotype in the VP1 region, as
is expected since VP1 is the basis of serotype designation. E13
strains differed little genetically in all regions, by 0–8.3% in VP1,
0–14.9% in 2C and 0–7.7% in 3D. Phylogenetic trees also showed
consistent grouping in all regions for these strains, all isolated in
Figure 5. Phylogenetic tree of E30 isolates. 5 groups were observed, with all Marseille isolates clustering in group 5. Closer look at group 5
shows that the most Marseille isolates are genetically related, including all strains from the 2000 and 2005 epidemics. #553 (diamond) differs
genetically from #497 (circle) and prototype Giles (square) by 0.157 and 0.312 respectively.
doi:10.1371/journal.pone.0018022.g005
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E13 strains in Marseille. In contrast, CVB3 strains were more
genetically distant, with 5.2–47.1% in VP1, 52.3–80.2% in 2C and
13.7–81.2% in 3D. Their greater diversity is reinforced by
inconsistent clustering across the genome. It is thus highly possible
that recombination events have occurred involving the nonstruc-
tural region of CVB3 strains. E30 on the other hand, is a more
complex case: three strains isolated between 1987 and 1988
demonstrated little divergence with maximum p-distance of 4.3%,
5% and 8.5% in the VP1, 2C and 3D regions respectively and
consistent clustering with one another in all regions. However, the
remaining E30 strains presented greater genetic distance, by 0–
20.7% in VP1, 64.1–75.2% in 2C and 62–88.6% in 3D. This
disparity is also observed in their variable phylogenetic positions
across the genome.
This pattern is exemplified by E30 strains #405559 and
#404728, both isolated in 2000 and which are identical (p-
distance =0%) in their VP1 nucleotide sequence but differ by
73.3% and 74.2% in their 2C and 3D sequences respectively.
Interestingly, the exact opposite clustering pattern was observed in
7 strains: 1 E30 (#406559), 1 CVA9 (#406891), 1 E25 (#406788)
and 4 E13 (#406401, #406050, #406119 and #406241) strains
differed by a maximum 92.6% in their VP1 region, but only by
14.9% in 2C and 8.5% in 3D. Phylogenetic analysis showed
reliable grouping (bootstrap =100%) in both the 2C and 3D
regions for our cluster of interest.
Discussion
The present study describes the frequency of enteroviral
serotypes isolated in Marseille between 1985 and 2005. Entero-
viruses are known to circulate in the summer and autumn months
in temperate regions [19,29–30]. In Marseille, we observed that
HEV isolation peaked in the spring and summer months, notably
during the 2000 and 2005 epidemics when unusual levels of HEV
activity were detected as early as May. The last natural case of
poliovirus in Marseille was described in 1988, in line with its
complete elimination in France and the European continent in
1990 [31]. E30 was the most frequent enterovirus isolated in
Marseille, in accordance with epidemiological data collected by
the RSE, the sentinel laboratory network for the surveillance of
Enteroviruses in France [30]. This high incidence also reflects
similar circulation levels and the occurrence of E30-associated
aseptic meningitis epidemics in 2000–2001 in North and South
America, Europe and Asia [23–24,32]. The general distribution of
E30 is temporally consistent with other European strains included
in our analysis, and supports a microevolution as a continuous
cline with rare re-emergence of more ancient strains. Unlike E30,
E13 was considered a rare serotype with no outbreaks associated
with this virus and had only ever been isolated once in Marseille
prior to 2000. Its sudden emergence as a predominant serotype
was also observed in other countries: in the United States, E13
accounted for 24% of all reported HEV isolates in 2001,
compared to 1.6% in 2000 [33]. In Japan, E13 had only been
isolated once before 2001, during which 65 strains were isolated
[34]. E13 was first identified in Spain during an aseptic meningitis
outbreak in 2000 [35].
Regarding the strategies and methodologies used during the
study period for detection and characterization of enteroviruses, a
number of observations could be made. Firstly, stool has been the
most frequently used sample type for enterovirus isolation, and the
most useful since it allowed the isolation of all serotypes. Secondly,
MRC5 was the most conducive cell line for enterovirus isolation,
and coupling with BGM cell line, resulted in a more extensive
coverage for HEV-B strains. Thirdly, seroneutralization-based
HEV typing showed 55.4% accuracy when compared to VP1
sequence analysis. This divergence in identification may be
explained in part by technical insufficiency of the seroneutraliza-
tion typing protocol (e.g. cross reacting activity, use of pools raised
against strains prevalent more than 30 years ago). Another possible
Figure 6. Phylogenetic tree of E13 isolates. All but two sequences were isolated between 2000 and 2002, and clustered in a distinct group. The
greatest genetic distance was observed between #369 (clear triangle), isolated in 1987, and #375 (filled triangle), isolated in 2000.
doi:10.1371/journal.pone.0018022.g006
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PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e18022Figure 7. Phylogenetic trees of HEV-B in the VP1 (A), 2C (B) and 3D (C) regions. Inconsistent topologies suggest possible recombination
events, especially in the case of E30 (red) and CVB3 (green). E13 clinical isolates (blue) however, differed little genetically across the genome,
suggesting the absence of major recombination events. Our cluster of interest includes 7 strains (4 E13, 1 E30, 1 CVA9 and 1 E25) that group reliably
(bootstrap 100%) in the 2C and 3D regions but not in the VP1 region.
doi:10.1371/journal.pone.0018022.g007
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patient sample, whereby the dominant serotype during its
reproduction in culture for VP1 sequencing is different from the
dominant serotype during initial culture for diagnostic seroneu-
tralization. It has also been highlighted that poliovirus might be
present in working stocks of other viruses, even when unambig-
uously identified and labeled [36].
The validity of VP1 serotyping protocol and pairwise genetic
distance analysis has been primarily established with enterovirus
prototype sequences or with clinical sequences spanning a short
period of time [7]. Our analysis of a large number of clinical
isolates over 20 years reinforces the pertinence of this technique
that allows the identification of most HEV sequences using the
simple computationally non-intensive genetic distance calculation.
Furthermore, in the few instances whereby the genetic diversity
within a serotype can be so significant as to exceed the 0.25
threshold, as observed in E30, genetic distance can be coupled
with the phylogenetic analysis of VP1 to provide a non-ambiguous
identification of HEV, a strategy previously validated with the
delineation of Hepatitis C virus genotypes [37–38].
The serotypic identification of enteroviruses is challenged by the
existence of recombination events [39–40]. Isolates sharing similar
VP1 genes but differing in other parts of the genome may display
different epidemiological or clinical properties. Phylogenetic topolo-
gies of different portions of the enteroviral genome describe HEV
strains with genetically consistent VP1 regions and more inter-
changeable 2C and 3D regions, particularly demonstrated by E30
and CVB3 strains from Marseille. This suggests that closely related
VP1 regions can be associated with divergent 2C and 3D regions.
The mechanism of RNA recombination in enteroviruses is
commonly accepted to involve template switching during RNA
synthesis, with recombination points most frequentlyidentified within
the nonstructural region [28,41]. In contrast, we observed the
opposite trend in an unusual cluster of 7 strains: #406891_CVA9,
#406401_E13, #406050_E13, #406119_E13, #406241_E13,
#406788_E25 and #406559_E30 showed little similarity in the
VP1 region, but a marked resemblance in the nonstructural region.
This suggests the circulation of highly similar HEV strains which
differ primarily in the region by which they are attributed serotypes.
Considering that all 7 strains were isolated during the 2000 Marseille
epidemic during which the E30 and E13 serotypes were particularly
prominent, this genetic similarity could explain the emergence of E13
as an epidemic serotype by a recombination between circulating E13
and epidemic E30 strains. This might also account for the lack of
direct correlation between serotype and pathology, such as how
several (VP1-defined) serotypes can provoke the same clinical
manifestations. A new model of enteroviral genetics has been
suggested, such that enteroviruses should be regarded as a pool of
independently evolving genomic fragments [42]. We show that
clinicalstrains of enteroviruses circulating over 20years lend credence
to this model by showing the inadequacies of the current model of
demarcated serotypes.
In this work, serotypes from the HEV-B species account for
98% of all isolates in Marseille. This echoes HEV-B levels
described in Spain (89.3%) [43], in the United States (89.5%) [19]
and in Tunisia (92.2%) [44], studies which also used cell culture to
first isolate the virus in the typing process. However, the use of cell
culture techniques may distort any derived epidemiological data
since some HEV serotypes (Coxsackievirus A and certain
numbered HEVs) do not grow or grow poorly in cell culture,
and suggests that the proportion of circulating non HEV-B
serotypes has been underestimated. Such a study of clinical
samples in a clinical virology laboratory is sure to encounter some
limitations, in part by the bias associated with cell culture
techniques, but also by other factors such as patient sample
referral and enteroviral disease presentations that might not be
actively investigated. This work should thus be more accurately
regarded as a clinical profile of HEV-B serotypes in Marseille. As
such, we feel the need to reinforce efforts for identifying HEV
directly from clinical samples, bypassing the need for cell culture
systems.
Materials and Methods
Marseille HEV strain collection and sequence database
Enterovirus samples. All samples taken for diagnostic
purposes are accessible for research under French national
regulations regarding biomedical research (Loi Huriet-Se ´rusclat
(loi 881138)) without requiring neither specific written consent
from the patient nor approval from an ethics committee. All
clinical samples were obtained from the Laboratory of Virology,
University Hospital La Timone (Marseille, France) from 1985 to
2005. Specimen types comprised of nasopharyngeal swabs, stool,
cerebrospinal fluid, saliva and bronchoarterial specimens.
Cell lines. MRC5 cells (Human fetal lung fibroblasts) were
cultured in Basal Medium Eagle (BME), 10% decomplemented
Fetal Bovine Serum (dFBS), 1% L-Glutamine (L-GLN), 1%
Penicillin-Streptomycin (PS). Hep2 (Human laryngeal carcinoma
cells), KB (Human laryngeal carcinoma cells), Vero (African green
monkey kidney cells) and BGM (Buffalo green monkey kidney
cells) cell lines were grown in Minimum Essential Medium Eagle
(MEM), 5% dFBS, 1% L-GLN, 1% PS. All cell cultures were
incubated at 37uC under 5% CO2.
Enterovirus diagnosis. (i) Prior to 2000, HEV diagnosis
consisted of growing samples in cell culture in MRC5, BGM, Vero
and KB cell lines. Once cytopathic effect (CPE) was observed, the
presence of HEV antigen was tested by immunofluorescence with
a monoclonal mouse anti-EV antibody (clone 5-D8/1, Dako) and
a secondary goat anti-IgG mouse fluorescein conjugate [45]; (ii)
From 2000 to 2004, diagnosis was achieved by classic RT-PCR
using the Enterovirus Consensus Kit 5 (Argene) and inoculation of
samples onto MRC5, BGM, Vero and Hep2 cell lines which were
similarly evaluated by CPE and immunofluorescence; (iii) From
2005 onwards, a real-time pan-enterovirus RT-PCR was used
(adapted from [5]) along with the inoculation of samples onto
MRC5, BGM, Vero and Hep2 cell lines which were similarly
evaluated by CPE and immunofluorescence. For all samples, the
cell line in which CPE was most rapidly observed was recorded
and the virus isolates stored in the Marseille Public Hospitals virus
collection. Globally, from 1985 to 2005, the same cell culture
detection and isolation protocol was performed based on the use of
MRC5, Vero and BGM cells, which represent 96.5% of all isolates
(cf Results section). The only change during the period was the
replacement of KB with Hep2 cells from 2000 onwards, and which
represent 0.5% and 3% of all isolates respectively).
Seroneutralization. A portion of HEV-positive samples
(n=204) processed between 1985 and 1994 were typed by
seroneutralization with Lim-Benyesh-Melnick antiserum pools [6].
VP1 Sequencing. Strains recorded in the Marseille HEV
collection were reproduced in the cell line in which they were
originally isolated from culture. Supernatant was clarified by
centrifugation and extracted using the EZ1 Virus Mini Kit (Virus
Card 2.0) in an EZ1 BioRobot (QIAGEN) according to the
manufacturer’s protocol. Reverse transcription was carried out
with Reverse Transcriptase MultiScribe (Applied Biosystems) with
random hexamers. Each viral cDNA was then amplified by nested
Taq DNA Polymerase PCR (Invitrogen) using 2 VP1-specific
primer pairs (adapted from [7]). Amplification products were
Enterovirus Diagnosis and Molecular Epidemiology
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bromide staining, then purified with QIAquick PCR Extraction
or Gel Extraction kits (QIAGEN). Sequencing was carried out
using a Big Dye Terminator Cycle Sequencing Reaction kit and
an ABI Prism 3130 DNA Sequencer (Applied Biosystems).
Marseille HEV sequence database. VP1 sequences were
obtained and their serotype identified by phylogenetic analysis
(n=654).They werearchived in the MarseilleHEVVP1 databasein
the following format: #Reference number_Year_Sample type_Cell
line_Serotype. No written patient consent was required as all strains
were characterized for etiological purposes.
2C and 3D sequencing. HEV-B strains from the HEV
database (n=65) were chosen to be representative of serotypes and
years for the period surveyed. 2C, coding region for the helicase/
NTPase; and 3D, coding region for the RNA-dependent RNA
polymerase, were chosen as representative of the P2 and P3
regions respectively. We designed primer pairs to specifically
amplify HEV-B serotypes, targeting portion of the 2C and 3D
regions that phylogenetically distinguished HEV-B from other
HEV species. RT-PCR was performed as described above, using
the specific primer pairs 2C-F (TTYGAYGGiTAYAARCARCA)
and 2C-R (GGiCCYTGRAAiARiGCYTC) or 3D-2F (TTYT-
GGWSiAARATHCCiGT) and 3D-R (CKiACRTGRTCYTGiG-
TRTT). Amplification products were visualized, purified and
sequenced as described above.
Sequence analysis
Phylogenetic analysis. All sequence chromatograms were
analysed with Sequencher 4 software (Gene Codes Corporation).
Multiple sequence alignments were realized with EBI ClustalW2
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) [46] on default
settings and manually edited with BioEdit [47]. The nucleotide
sequences were translated into and aligned as amino acids. Using the
programme DAMBE (http://dambe.bio.uottawa.ca/dambe.asp)
[48], nucleotide sequences were aligned against the amino acid
sequences. Phylogenetic trees were constructed with MEGA version
3.1 (Molecular Evolutionary Genetics Analysis) [49]. For VP1, 2C
and 3D, this was achieved using the Neighbor-Joining method on a
Jukes-Cantor model. Partial VP1 sequences (,400 nucleotides) were
omitted from phylogenetic analysis. Pairwise distance matrices were
drawn to calculate p-distance, the proportion of nucleotide sites at
which the two sequences differ for the totality of the sites compared.
The consistency of tree topologies was tested by bootstrapping in
1000 pseudoreplicates.
Statistical analysis of epidemiological data
A Classification and Regression Tree (CART) was established to
determine characteristic features of the dataset as a series of if-then
logical conditions [50]. The monthly frequency of Enterovirus
isolations was plotted on a control chart for count data (Poisson
distribution) estimating an upper control limit with m 63s
(99.73% confidence) [51–52]. Statistical analysis was carried out
using the R.2.10.1 environment (http://www.r-project.org) and
the qcc package [53].
Supporting Information
Figure S1 Pairwise p-distance scores of clinical Entero-
virus VP1 sequences, 1985-2005. 20 years of clinical strains
validated the three established ranges of genetic distance that
indicate variants of the same serotype (#0.25), sequences of
different serotypes but the same species (.0.25 and ,0.42), or
sequences of different species ($0.42).
(TIF)
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